Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1

Interventions

pembrolizumab 15 Nivolumab 10 Ipilimumab 7 cemiplimab 6 dabrafenib 4 binimetinib 4 Dacarbazine 4 trametinib 3 encorafenib 3 Drug Therapy 3 Allovectin-7 3 zanolimumab 2 talabostat 2 lifileucel 2 aldesleukin 2 Vemurafenib 2 Tablets 2 Semaxinib 2 Intravital Microscopy 2 Interleukin-2 2 Fluorouracil 2 vitespin 1 veliparib 1 varlilumab 1 tozuleristide 1 tin etiopurpurin 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Skin Neoplasms × Workplace × Clear all

NCT05146622 2022-11-04

SSW Works

Klein Buendel, Inc.

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡